![](/img/cover-not-exists.png)
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs. conventional fibrinolytic therapy for acute myocardial infarction. GUSTO V randomized trial
A.M. Lincoff, R.M. Califf, F. Van de WerfVolume:
12
Year:
2003
Language:
english
DOI:
10.1016/s1062-1458(02)01006-1
File:
PDF, 35 KB
english, 2003